149 related articles for article (PubMed ID: 19783902)
1. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells.
Dong W; Shen R; Wang Q; Gao Y; Qi X; Jiang H; Yao J; Lin X; Wu Y; Wang L
Cancer Biol Ther; 2009 Nov; 8(22):2166-74. PubMed ID: 19783902
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro.
Pal D; Sharma U; Singh SK; Kakkar N; Prasad R
PLoS One; 2015; 10(3):e0115651. PubMed ID: 25730259
[TBL] [Abstract][Full Text] [Related]
3. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
[TBL] [Abstract][Full Text] [Related]
4. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.
Takami Y; Russell MB; Gao C; Mi Z; Guo H; Mantyh CR; Kuo PC
Surgery; 2007 Aug; 142(2):163-9. PubMed ID: 17689681
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor Sp1 prevents TRF2(ΔBΔM)-induced premature senescence in human diploid fibroblasts.
An HJ; Lee HJ; Jang S; Jung YJ; Choi SS; Park SC; Han JA
Mol Cell Biochem; 2016 Mar; 414(1-2):201-8. PubMed ID: 26906205
[TBL] [Abstract][Full Text] [Related]
6. TRF2 promotes multidrug resistance in gastric cancer cells.
Ning H; Li T; Zhao L; Li T; Li J; Liu J; Liu Z; Fan D
Cancer Biol Ther; 2006 Aug; 5(8):950-6. PubMed ID: 16760674
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
Zhang Y; Zeng D; Cao J; Wang M; Shu B; Kuang G; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3246-3256. PubMed ID: 28943299
[TBL] [Abstract][Full Text] [Related]
8. Expression of the proto-oncogene Pokemon in colorectal cancer--inhibitory effects of an siRNA.
Zhao GT; Yang LJ; Li XX; Cui HL; Guo R
Asian Pac J Cancer Prev; 2013; 14(9):4999-5005. PubMed ID: 24175766
[TBL] [Abstract][Full Text] [Related]
9. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells.
Jiao Y; Zhang W; Liu J; Ni W; Xu W; Jin J; Qian W
Cancer Biol Ther; 2007 Aug; 6(8):1186-92. PubMed ID: 17643074
[TBL] [Abstract][Full Text] [Related]
10. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
11. Curcusone C induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
Wang M; Cao J; Zhu JY; Qiu J; Zhang Y; Shu B; Ou TM; Tan JH; Gu LQ; Huang ZS; Yin S; Li D
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1372-1382. PubMed ID: 28870734
[TBL] [Abstract][Full Text] [Related]
12. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
[TBL] [Abstract][Full Text] [Related]
13. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
Wu M; Lin Z; Li X; Xin X; An J; Zheng Q; Yang Y; Lu D
Sci Rep; 2016 Oct; 6():36045. PubMed ID: 27782152
[TBL] [Abstract][Full Text] [Related]
14. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review).
Wang Z; Wu X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278498
[TBL] [Abstract][Full Text] [Related]
15. Role of FBXL20 in human colorectal adenocarcinoma.
Zhu J; Li K; Dong L; Chen Y
Oncol Rep; 2012 Dec; 28(6):2290-8. PubMed ID: 23023584
[TBL] [Abstract][Full Text] [Related]
16. Upregulation and CpG island hypomethylation of the TRF2 gene in human gastric cancer.
Dong W; Wang L; Chen X; Sun P; Wu Y
Dig Dis Sci; 2010 Apr; 55(4):997-1003. PubMed ID: 19399616
[TBL] [Abstract][Full Text] [Related]
17. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
Jiang WQ; Zhong ZH; Henson JD; Reddel RR
Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
[TBL] [Abstract][Full Text] [Related]
18. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.
Li S; Wang Q; Qiang Q; Shan H; Shi M; Chen B; Zhao S; Yuan L
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1909-20. PubMed ID: 25773124
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine causes telomere attrition by stabilizing TRF2.
Su CH; Chu WC; Lan KH; Li CP; Chao Y; Lin HC; Lee SD; Tsai YC; Lee WP
Eur J Cancer; 2012 Dec; 48(18):3465-74. PubMed ID: 22704123
[TBL] [Abstract][Full Text] [Related]
20. The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine.
Zhang YW; Zhang ZX; Miao ZH; Ding J
Mol Pharmacol; 2008 Mar; 73(3):824-32. PubMed ID: 18025071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
